NCT02233894View on ClinicalTrials.gov

Post-marketing Surveillance of Atrovent® Inhalets in Chronic Obstructive Pulmonary Disease

CompletedOBSERVATIONAL
Enrollment

526

Participants

Timeline

Start Date

February 28, 2001

Primary Completion Date

May 31, 2002

Conditions
Pulmonary Disease, Chronic Obstructive
Interventions
DRUG

Atrovent® - inhalets

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY